Relaunch

[anonymous]

what region did the last person quit from?

Pretty sure every month people have quit

 

[anonymous]

what region did the last person quit from?

Pretty sure every month people have quit

Most territories are being left empty which makes you wonder why they can’t even convince an Enterprise kid to take this job.

 

[anonymous]

Another one bites the dust. How many reps have quit recently? Supernus will need to “relaunch” a new Salesforce here pretty soon.

Good riddance I for one love being a part of a company that has my best interest at heart,! Management has never failed to do the right thing!

 

[anonymous]

Potiga

 

[anonymous]

Good riddance I for one love being a part of a company that has my best interest at heart,! Management has never failed to do the right thing!

GC email really made my month, they’re so, so proud of us!

 

[anonymous]

more people quitting this shit show

from the outside get out get out get out!!

 

[anonymous]

I guess home office has already powered down for the year. Gary where is my data?

 

[anonymous]

Merry Christmas. Now go have fun with your family and get off cafepharma. Try to find the good in things!

 

[anonymous]

Remember that one time that Supernus told us to encourage our doctors to push the dose to 400MGs with children. That was awesome.

 

[anonymous]

Interesting we don’t have the OLE data. When they showed it at the last POA briefly it didn’t look that impressive, is that why? We only have OLE dosing? I’ll say it again, why are we having this POA in person? Could have been done virtual in one day. Nothing is new, SSP is the same. Waste of money and time out of the field.

 

[anonymous]

Interesting we don’t have the OLE data. When they showed it at the last POA briefly it didn’t look that impressive, is that why? We only have OLE dosing? I’ll say it again, why are we having this POA in person? Could have been done virtual in one day. Nothing is new, SSP is the same. Waste of money and time out of the field.

It’s called “micromanagement”

 

[anonymous]

We talk plenty about no drug to drug interactions with Qelbree and amphetamines and methylphenidate drugs in our SSP. Not one time do we mention in our SSP that Qelbree was studied for monotherapy.

Despicable

 

[anonymous]

We talk plenty about no drug to drug interactions with Qelbree and amphetamines and methylphenidate drugs in our SSP. Not one time do we mention in our SSP that Qelbree was studied for monotherapy.

Despicable

Wait. Do you think investigational drugs go through a phIII trial with each potential adjunctive med to show drug to drug interaction?

 

[anonymous]

Wait. Do you think investigational drugs go through a phIII trial with each potential adjunctive med to show drug to drug interaction?

Nice attempted pivot. I was pointing out that we mention no drug to drug interactions but we never mention once that Qelbree was studied as monotherapy. This is intentionally misleading to doctors and is illegal.

 

[anonymous]

Wait. Do you think investigational drugs go through a phIII trial with each potential adjunctive med to show drug to drug interaction?

I think the OP was pointing out that we are making it seem like we have the add on indication. Notating D2D interactions and not mentioning we are mono only.

 

[anonymous]

Nice attempted pivot. I was pointing out that we mention no drug to drug interactions but we never mention once that Qelbree was studied as monotherapy. This is intentionally misleading to doctors and is illegal.

Perhaps corporate accounts can enable us to use this claim. Until then, no such message will ever be promoted. Keep running the card while you can!

 

[anonymous]

Perhaps corporate accounts can enable us to use this claim. Until then, no such message will ever be promoted. Keep running the card while you can!

While we can? That’s hilarious. Take that card away and we will never grow a script nationally again. As far as making claims based off Corporate Accounts, without FDA approval we can’t make or imply the adjunctive option. Full stop.

 

[anonymous]

We talk plenty about no drug to drug interactions with Qelbree and amphetamines and methylphenidate drugs in our SSP. Not one time do we mention in our SSP that Qelbree was studied for monotherapy.

Despicable

This is a joke right? PK studies were performed, (as they are for all drugs approved by the FDA) read the label.

 

[anonymous]

This is a joke right? PK studies were performed, (as they are for all drugs approved by the FDA) read the label.

Not disputing D2D interactions with the stimulants. I am pointing out that we do not mention MONOTHERAPY one time in our SSP!!! When we speak of D2D interactions we are alluding to doctors it's indicated as add on.

 

[anonymous]

Not disputing D2D interactions with the stimulants. I am pointing out that we do not mention MONOTHERAPY one time in our SSP!!! When we speak of D2D interactions we are alluding to doctors it's indicated as add on.

FDA Hotline Bling